Results 51 to 60 of about 179,968 (219)

Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced, PD-L1–positive papillary or follicular thyroid cancer

open access: yesBMC Cancer, 2019
Treatment options for advanced thyroid cancer refractory to standard therapies are limited. The safety and efficacy of pembrolizumab were evaluated in patients with advanced differentiated thyroid cancer expressing programmed death ligand 1 (PD-L1 ...
J. Mehnert   +14 more
semanticscholar   +1 more source

The Association Between Preoperative Serum Thyroid-Stimulating Hormone and Neutrophil-Lymphocyte Ratio as Predictors of Papillary Thyroid Cancer

open access: yesJBN (Jurnal Bedah Nasional)
Aim: This study aims to evaluate the correlation between blood thyroid stimulating hormone levels and neutrophil lymphocyte ratio prior to thyroidectomy in patients with papillary thyroid cancer, as well as the potentiality of those as predictors of ...
William Stevenson   +3 more
doaj   +1 more source

Cell division cycle 45 promotes papillary thyroid cancer progression via regulating cell cycle

open access: yesTumor Biology, 2017
Cell division cycle 45 was reported to be overexpressed in some cancer-derived cell lines and was predicted to be a candidate oncogene in cervical cancer.
Jing Sun   +6 more
doaj   +1 more source

An enlarging neck mass with dyspnea and left finger pain in a 63‐year‐old woman

open access: yesClinical Case Reports, 2021
We described a rare presentation of papillary thyroid cancer metastasized to left finger. This case highlights the importance of an early and effective engagement of multidisciplinary team approach to optimize patient care and that papillary thyroid ...
Thanh D. Hoang   +2 more
doaj   +1 more source

miR‐451a inhibits cancer growth, epithelial‐mesenchymal transition and induces apoptosis in papillary thyroid cancer by targeting PSMB8

open access: yesJournal of Cellular and Molecular Medicine, 2019
Despite the increasing incidence of papillary thyroid cancer in the past decade, the molecular mechanism underlying its progression remains unknown.
Xinlong Fan, Yuejiao Zhao
semanticscholar   +1 more source

Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.

open access: yesJournal of Clinical Endocrinology and Metabolism, 2016
CONTEXT Individualized management, incorporating papillary thyroid cancer (PTC) variant-specific risk, is conceivably a useful treatment strategy for PTC, which awaits comprehensive data demonstrating differential risks of PTC variants to support ...
Xiaoguang Shi   +47 more
semanticscholar   +1 more source

Mönckeberg sclerosis in patients with thyroid papillary carcinoma

open access: yesEndocrine Oncology
Background: Mönckeberg sclerosis is a form of calcification of the tunica media of small and medium size arteries. It occurs more often in the peripheral arteries of the lower limbs and it has been associated with diabetes and renal disease.
Vasiliki Venetsanaki   +9 more
doaj   +1 more source

Effect of a Change in Papillary Thyroid Cancer Terminology on Anxiety Levels and Treatment Preferences: A Randomized Crossover Trial

open access: yesJAMA Otolaryngology - Head and Neck Surgery, 2018
Importance Given evidence of overdiagnosis and overtreatment of small papillary thyroid cancers (PTCs), strategies are needed to promote the consideration of less invasive treatment options for patients with low-risk PTC.
B. Nickel   +6 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy